StemExpress is providing molecular testing via Emergency Use Authorization (EUA) from the FDA. Our service is comprehensive from registration, sample collection, testing, data generation, and result reporting. Specimen collections and COVID-19 testing can be done on-site or at a specified StemExpress location.
COVID-19 testing services available for:
- Frontline Workforce
Two types of testing platforms will be available, Molecular and Antibody.
Molecular Testing (RT-PCR)
Nasopharyngeal swab samples will be collected from participants and sent to one of our six Collection Centers for RT-PCR testing using Thermo Fisher’s Applied Biosystems TaqPath™ Assay technology. This highly sensitive diagnostic test provides fast and reliable results. Through this testing, positive results are indicative of a current SARS-CoV-2 infection.
Lateral flow immunoassay is a rapid serological test for the qualitative detection of IgG and IgM antibodies against SARS-CoV-2 in the blood. The presence of the antibodies can identify participants that may have been infected at a previous point in time.
ELISA is a highly sensitive plate-based assay for the detection and quantification of specific antibodies in the blood against the SARS-CoV-2 virus. Detection of antibodies against the SARS-CoV-2 virus indicates positive results for a previous infection.
Please be aware that the results from the Molecular or Antibody tests, whether positive or negative, must be combined with clinical observations, patient history, and epidemiological information for a proper medical diagnosis.
For up-to-date information on the SARS-CoV-2 outbreak, visit the WHO or CDC websites.